Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences

INTRODUCTION: This study evaluated patients’ experiences with fluticasone furoate/vilanterol (FF/VI) combination therapy in UK patients with asthma or chronic obstructive pulmonary disease (COPD). METHODS: Participants aged ≥ 18 years, with self-reported, physician-diagnosed asthma or COPD (≥ 1 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Svedsater, Henrik, Doll, Helen A., Macey, Jake, Miles, Gail, Bradshaw, Lisa, Vanya, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133131/
https://www.ncbi.nlm.nih.gov/pubmed/30105658
http://dx.doi.org/10.1007/s12325-018-0760-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133131/
https://www.ncbi.nlm.nih.gov/pubmed/30105658
http://dx.doi.org/10.1007/s12325-018-0760-7

Ejemplares similares